First Trust Advisors LP Increases Stake in Zimmer Biomet

Hedge fund boosts ownership of medical equipment provider by over 60% in Q3

Mar. 13, 2026 at 7:54am

Got story updates? Submit your updates here. ›

First Trust Advisors LP increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 62.6% during the 3rd quarter, according to the company's 13F filing with the Securities and Exchange Commission. The fund now owns 406,057 shares of the medical equipment provider's stock, worth nearly $40 million.

Why it matters

Zimmer Biomet is a major manufacturer of orthopedic implants and other medical devices. The increase in First Trust Advisors' stake suggests the hedge fund sees growth potential in the company, which could signal broader investor confidence in Zimmer Biomet's business outlook.

The details

First Trust Advisors purchased an additional 156,388 shares of Zimmer Biomet during the third quarter, bringing its total ownership to 0.20% of the company's outstanding stock. The hedge fund's increased investment comes as Zimmer Biomet navigates a competitive medical device market and works to integrate recent acquisitions.

  • First Trust Advisors increased its stake in Zimmer Biomet during the 3rd quarter of 2026.
  • The 13F filing disclosing the increased stake was published on March 13, 2026.

The players

First Trust Advisors LP

An investment management firm that oversees over $200 billion in assets.

Zimmer Biomet Holdings, Inc.

A global medical device company focused on musculoskeletal healthcare, headquartered in Warsaw, Indiana.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

The increased stake by First Trust Advisors suggests the hedge fund sees long-term growth potential in Zimmer Biomet, a leading player in the orthopedic device market. This could signal broader investor confidence in the company's ability to navigate industry challenges and capitalize on emerging trends in musculoskeletal healthcare.